Hospitalisation risk for COVID-19 patients infected with SARS-CoV-2 variant B.1.1.7: cohort analysis
Authors:
Tommy Nyberg,
Katherine A. Twohig,
Ross J. Harris,
Shaun R. Seaman,
Joe Flannagan,
Hester Allen,
Andre Charlett,
Daniela De Angelis,
Gavin Dabrera,
Anne M. Presanis
Abstract:
Objective: To evaluate the relationship between coronavirus disease 2019 (COVID-19) diagnosis with SARS-CoV-2 variant B.1.1.7 (also known as Variant of Concern 202012/01) and the risk of hospitalisation compared to diagnosis with wildtype SARS-CoV-2 variants.
Design: Retrospective cohort, analysed using stratified Cox regression.
Setting: Community-based SARS-CoV-2 testing in England, individu…
▽ More
Objective: To evaluate the relationship between coronavirus disease 2019 (COVID-19) diagnosis with SARS-CoV-2 variant B.1.1.7 (also known as Variant of Concern 202012/01) and the risk of hospitalisation compared to diagnosis with wildtype SARS-CoV-2 variants.
Design: Retrospective cohort, analysed using stratified Cox regression.
Setting: Community-based SARS-CoV-2 testing in England, individually linked with hospitalisation data.
Participants: 839,278 laboratory-confirmed COVID-19 patients, of whom 36,233 had been hospitalised within 14 days, tested between 23rd November 2020 and 31st January 2021 and analysed at a laboratory with an available TaqPath assay that enables assessment of S-gene target failure (SGTF). SGTF is a proxy test for the B.1.1.7 variant. Patient data were stratified by age, sex, ethnicity, deprivation, region of residence, and date of positive test.
Main outcome measures: Hospitalisation between 1 and 14 days after the first positive SARS-CoV-2 test.
Results: 27,710 of 592,409 SGTF patients (4.7%) and 8,523 of 246,869 non-SGTF patients (3.5%) had been hospitalised within 1-14 days. The stratum-adjusted hazard ratio (HR) of hospitalisation was 1.52 (95% confidence interval [CI] 1.47 to 1.57) for COVID-19 patients infected with SGTF variants, compared to those infected with non-SGTF variants. The effect was modified by age (P<0.001), with HRs of 0.93-1.21 for SGTF compared to non-SGTF patients below age 20 years, 1.29 in those aged 20-29, and 1.45-1.65 in age groups 30 years or older.
Conclusions: The results suggest that the risk of hospitalisation is higher for individuals infected with the B.1.1.7 variant compared to wildtype SARS-CoV-2, likely reflecting a more severe disease. The higher severity may be specific to adults above the age of 30.
△ Less
Submitted 29 May, 2021; v1 submitted 12 April, 2021;
originally announced April 2021.
Spatiotemporal map** of malaria prevalence in Madagascar using routine surveillance and health survey data
Authors:
Rohan Arambepola,
Suzanne H. Keddie,
Emma L. Collins,
Katherine A. Twohig,
Punam Amratia,
Amelia Bertozzi-Villa,
Elisabeth G. Chestnutt,
Joseph Harris,
Justin Millar,
Jennifer Rozier,
Susan F. Rumisha,
Tasmin L. Symons,
Camilo Vargas-Ruiz,
Mauricette Andriamananjara,
Saraha Rabeherisoa,
Arsène C. Ratsimbasoa,
Rosalind E. Howes,
Daniel J. Weiss,
Peter W. Gething,
Ewan Cameron
Abstract:
Malaria transmission in Madagascar is highly heterogeneous, exhibiting spatial, seasonal and long-term trends. Previous efforts to map malaria risk in Madagascar used prevalence data from Malaria Indicator Surveys. These cross-sectional surveys, conducted during the high transmission season most recently in 2013 and 2016, provide nationally representative prevalence data but cover relatively short…
▽ More
Malaria transmission in Madagascar is highly heterogeneous, exhibiting spatial, seasonal and long-term trends. Previous efforts to map malaria risk in Madagascar used prevalence data from Malaria Indicator Surveys. These cross-sectional surveys, conducted during the high transmission season most recently in 2013 and 2016, provide nationally representative prevalence data but cover relatively short time frames. Conversely, monthly case data are collected at health facilities but suffer from biases, including incomplete reporting.
We combined survey and case data to make monthly maps of prevalence between 2013 and 2016. Health facility catchments were estimated and incidence surfaces, environmental and socioeconomic covariates, and survey data informed a Bayesian prevalence model. Prevalence estimates were consistently high in the coastal regions and low in the highlands. Prevalence was lowest in 2014 and peaked in 2015, highlighting the importance of estimates between survey years. Seasonality was widely observed. Similar multi-metric approaches may be applicable across sub-Saharan Africa.
△ Less
Submitted 19 August, 2020;
originally announced August 2020.
